Novelrad
Minimally-invasive Suturing for Vascular and Heart Defect Closure
Company Overview
Snapshot
Founded in January 2019 by Netanel Sharabani and Ori Goldor, Novelrad operates with 1–10 employees. The company has secured one funding round and received a grant from EIC Accelerator in February 2024.
Business overview
Novelrad develops a micro sewing machine designed for minimally-invasive suturing, specifically targeting vascular and heart defect closure. This versatile suturing platform mimics the surgical 'gold standard' by deploying continuous suture patterns percutaneously. The device facilitates safe dilation and reliable closure by deploying a multipoint purse string suture at the beginning of a procedure, addressing multiple indications within the cardiovascular system and beyond. Novelrad operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics for healthcare providers.
Strategic signal
In February 2024, Novelrad was listed among the companies receiving support from the EIC Accelerator. This recognition from a prominent European innovation program signals strong validation of Novelrad's innovative medical device technology and its potential to address significant needs in cardiovascular surgery. For investors, this indicates a positive trajectory and potential for future growth and market adoption within the medical devices sector.
Log in to access full profile ›Company Intelligence Q&A
- When was Novelrad founded and by whom?
- Novelrad was founded in January 2019 by co-founders Netanel Sharabani and Ori Goldor.
- What was a significant development for Novelrad in early 2024?
- In February 2024, Novelrad received a grant from the EIC Accelerator, as part of the November 2023 cut-off results.
- What is the primary application of Novelrad's device?
- The device is designed for minimally-invasive suturing for vascular and heart defect closure, mimicking surgical 'gold standard' techniques.
- How does Novelrad's device facilitate surgical procedures?
- The Novelrad VCD deploys a multipoint purse string suture at the beginning of a procedure, enabling safe dilation and reliable closure, and offers an unprecedented range of bore sizes using a single device.